financetom
Business
financetom
/
Business
/
Lsi Industries Insider Sold Shares Worth $271,882, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lsi Industries Insider Sold Shares Worth $271,882, According to a Recent SEC Filing
Jun 17, 2024 1:56 PM

04:23 PM EDT, 06/17/2024 (MT Newswires) -- James E Galeese, Executive Vice President, CFO, on June 13, 2024, sold 18,421 shares in Lsi Industries ( LYTS ) for $271,882. Following the Form 4 filing with the SEC, Galeese has control over a total of 165,378 shares of the company, with 165,378 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/763532/000089225124000059/xslF345X03/form4.xml

Price: 14.52, Change: -0.16, Percent Change: -1.09

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bristol-Myers Squibb Reports Opdivo, Yervoy Combination's Continued Survival Benefit in Advanced Melanoma
Bristol-Myers Squibb Reports Opdivo, Yervoy Combination's Continued Survival Benefit in Advanced Melanoma
Sep 16, 2024
07:24 AM EDT, 09/16/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said Sunday that 10-year follow-up data from a phase 3 trial of Opdivo monotherapy and Opdivo in combination with Yervoy in advanced or metastatic melanoma showed continued long-term survival benefit. The trial enrolled 945 patients with previously untreated advanced melanoma and after a minimum follow-up of 10 years,...
Johnson & Johnson Says its Bladder Cancer Drug Combined With Cetrelimab Shows High Response Rate in Study
Johnson & Johnson Says its Bladder Cancer Drug Combined With Cetrelimab Shows High Response Rate in Study
Sep 16, 2024
07:42 AM EDT, 09/16/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday interim results from its phase 2 study of its experimental bladder cancer therapy, TAR-200, showed in combination with chemotherapy using cetrelimab, TAR-200 demonstrated a nearly double pathologic complete response to using chemotherapy alone on patients with muscle-invasive bladder cancer. Treatment-related adverse events occurred in 72%...
Exclusive-Credit Agricole CIB chooses carbon trading over gold, sources say
Exclusive-Credit Agricole CIB chooses carbon trading over gold, sources say
Sep 16, 2024
LONDON (Reuters) - France's second largest listed bank Credit Agricole has decided to replace precious metals with trading in the regulated carbon markets starting from 2025, three sources with knowledge of the matter told Reuters. The move signals the increasing attraction of the world's most valuable carbon market - the EU Emissions Trading System (ETS) - to European banks. Credit...
Trump Media Shares Rise Following 'What Appears to Be' an Assassinaton Attempt
Trump Media Shares Rise Following 'What Appears to Be' an Assassinaton Attempt
Sep 16, 2024
07:19 AM EDT, 09/16/2024 (MT Newswires) -- Trump Media & Technology Group ( DJT ) shares were up more than 1% in Monday's premarket activity, following an apparent assassination attempt Sunday on the company's namesake, former US President Donald Trump. The FBI said it is investigating what appears to be an attempted assassination of Trump at his Florida golf club....
Copyright 2023-2026 - www.financetom.com All Rights Reserved